With their widespread availability and increasing popularity, one key question remains: who should receive GLP-1 drugs
In real-world settings there is an array of factors that may contribute to non-persistence, including medication supply shortages, adverse effects, high out-of-pocket costs and real-world weight reduction not meeting the patients expectations.
A unique characteristic of presence of catalytic cysteine in the active site help them in thioltransferase activity instead of GSH transfer activity
N Engl J Med 377(12):11191131
Current UK guidelines advise against their use in pregnancy and recommend concurrent effective contraception for women using them during their reproductive years
This includes pharmacist oversight throughout the preparation process, rigorous quality control measures, and adherence to best practices for accuracy and consistency